How do social skills affect daily life for people with Alzheimer’s dementia?

News published on September 4, 2024

Participants are being recruited for the Social Cognition and Functioning in Alzheimer’s Dementia (SOCIAL) study at Oxford Health NHS Foundation Trust.

Oxford Health psychiatrist awarded £2.4 million Wellcome Career Development Award

News published on September 2, 2024

Dr Anya Topiwala, consultant psychiatrist at the Trust and Wellcome Clinical Career Development Fellow at the University of Oxford’s Big Data Institute, has been awarded a £2.4 million Wellcome Career Development Award to grow her research team.

New drug to treat patients in the early stages of Alzheimer’s

News published on August 23, 2024

This week, a product licence for the medicine lecanemab (Leqembi) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adult patients in the early stages of Alzheimer’s disease.

Largest ever trial of ketamine-assisted therapy for alcohol disorder now recruiting  

News published on August 9, 2024

The largest ever trial to investigate whether ketamine-assisted therapy could help people with alcohol problems stop drinking is now recruiting participants.  

OHFT Researchers, staff and partners meet the Cowley community

News published on August 8, 2024

Recently researchers, staff and colleagues from across Oxfordshire research held an informal drop in engagement session for women and children in Cowley.

New shingles vaccine could reduce risk of dementia – major study indicates

News published on July 25, 2024

The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine.

Recruitment open for healthy participants in the OxSENSE study

News published on July 19, 2024

University of Oxford and Oxford Health Biomedical Research Centre (OH BRC) supported researchers are recruiting participants for the Oxford Semaglutide and Cognition (OxSENSE) Study. The study is investigating the effects of a single-dose of semaglutide on cognition and energy in healthy volunteers.

New Therapeutic Approaches in Translational Mental Health

News published on July 18, 2024

Academia Meets Industry – Grand Challenges and New Horizons

Monday 16 September 2024, Mathematical Institute, Oxford

Open Day at Westgate Centre showcases Oxford’s groundbreaking research

News published on July 17, 2024

Recently, visitors to Oxford’s Westgate Centre were able to learn about the world-class healthcare research taking place in the city.

Oxford Health researcher contributes to article on new treatments for depression

News published on July 16, 2024

Dr Frederico Magalhaes, Consultant Child and Adolescent Psychiatrist at Oxford Health’s Child and Adolescent Mental Health Service (CAMHS) has contributed to a recent article published in the BMJ.